Global Orlistat Market, By Type (120mg, 60mg and others), By Application, (Weight-reducing Aid, and Others) And Opportunities And Forecast 2020-2027.

Orlistat Market Overview

The Orlistat market is projected to witness a significant growth during the forecast period. The Orlistat market growth is driven by the growing number of weight-loss awareness initiatives. Mainly, orlistat is used as an anti-obesity medication. Orlistat drug is that which aids in the reduction or control of body mass, either by decreasing cravings or increasing calorie consumption.

The rising prevalence of obesity and its related diseases is projected to drive orlistat market expansion. According to a National Family Health Survey done in 2015 in India, over 9.8 million men and over 20 million women are obese. India has the world's second-highest rate of obese children, with the number steadily growing by 3-5 million patients per year.

However, Side effects after consumption of Orlistat drug, patent expiry of blockbuster products, increasing competition in the generic sector, and high cost of the newly launched products are likely to hamper the growth of this market during the forecast period.

Covid-19 Impact on Orlistat Market:

In addition, the current Orlistat Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Orlistat Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Orlistat Market Segment Overview

On the basis of type, the global Orlistat market is segmented into 120mg, and 60mg. The 60mg drug held the major share in the global orlistat market. This segment is anticipated to witness a significant CAGR of over the forecast period. An individual ideally consumes 30% of their energy from fat, the 60-mg dose is better tolerated than the 120-mg dose, and gastrointestinal side effects are minimal. In addition to facilitating modest weight loss are the major factors driving the growth of the market.

In terms of application, the market is segmented into weight-reducing Aid, and Others. Among these weight-reducing aid segment is expected to hold the major share in the global market. The primary application of orlistat is as a weight-loss aid. It is the most effective weight loss medication.

Market Analysis, Insights and Forecast – By Type

·       120mg
·       60mg
·       Others

Market Analysis, Insights, and Forecast – By Application

·       Weight-reducing Aid
·       Others

Orlistat Market Regional Overview

The regional analysis include adoption of Orlistat products across North America, Europe, Asia-Pacific (APAC), Latin America Middle East & Africa (MEA). North America was the leading revenue contributor to the global Orlistat market in 2020. Obesity affects more than one-third of the US population, according to historical statistics. However, Asia-Pacific is expected to experience the fastest CAGR during the forecast period, due to rising demand for orlistat with increasing obesity issues. According to the World Health Organization, nearly 13% of the population was detected to have obesity in 2018. Childhood obesity is on the rise in developing countries, where it is approximately 30% percent higher than in developed countries.

Orlistat Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Orlistat Market, Key Players

·       Roche
·       GSK group
·       Teva
·       Sandoz(Novartis)
·       STADA-VN J.V.Co., Ltd
·       Hexal AG
·       National Company for Pharmaceutical Industry
·       Lunan Pharmaceutical Group Corporation
·       ZEIN pharmaceutical
·       HISUN